LATEST UPDATES » Vol 21, No 10, September 2017 – Cardiovascular diseases       » Test strips for cancer detection get upgraded with nanoparticle bling       » Smart nano-pesticide to combat soil and water contamination       » China plans to launch "brain project" by year end       » UNAIDS encourages Chinese to produce drugs for Africa       » Korea-Singapore Healthcare Incubator to support Korean firms in Singapore and Southeast Asia       » Nanomaterial wrap for improved tissue imaging      
Amorfix enters into agreement with a major global pharmaceutical company for Alzheimer's disease diagnostic
Innovation and development-

These terms are increasingly present in discussions of our modern society, especially in the pharma and biotechnological industry.

Nothing shows this better, than the fact that life sciences and biotechnology have become one of the most important sources of modern economic development. The PHARM Connect Congress gives a tailored space for the experts of the sector to achieve a stronger and faster growth in their businesses.

The 500 engaged visitors of the CEE region, from more than 20 countries demonstrate the success of PHARM Connect, which will be held for the fourth time on 26-27 February 2014. The high level forum- which has established itself as the market leader and the only regional pharmaceutical and biotechnology manufacturing event for the entire Central and Eastern European region- takes place in Budapest, Hungary, where leading service providers of the sector have the possibility to be seen and to meet the industry's relevant companies. The Events Group operates on an invitation – only basis in order to maintain the outstanding quality. In this manner, the invitees are assured to encounter partners with relevant business potential.

Among others, the business summit is unique because the TEG Group bases their events on insights of the field's experts. Performers - Top service providers and key decision makers are sharing their expertise in presentations, panel discussions and case studies reflecting the recent market trends, from engineering to production, supply chain and quality management. The professional input of TEG's Programme Advisory Committee further ensures the event accommodate the elite of the healthcare/ pharmaceutical and biopharma sectors. This year visitors can listen to topics like: Pharma Companies from Emerging Markets& Asia Pacific- Opportunity or Treat? – presented by István Király, GM of GlaxoSmithKline Biological; Centralised Model of Managing Transportation and Logistics in Europe- by Dr. Zvonimir Majic- the Head of Quality Assurance EU Logistics, TEVA Europe; Preparing for Regulatory Inspections – The Do's and the Don'ts and the Best Practices by Amer Alghabban- Director, Global QA Auditing of Merck, and many others.

The congress further provides an opportunity to visit GSK Biologicals plant or to have an excursion to the TEVA Logistics Centre.

The guests are given the chance to create their individual agenda in advanced, so they can pre-schedule meetings and presentations in the most efficient way, according to their interest.

The exclusive atmosphere, the focused presentations, pre-scheduled one-to-one business meetings and other formal and informal networking facilities are making The PHARM Connect Congress extremely efficient, unique and popular.

The event regularly takes places in the luxurious 5 star Corintia Grand Hotel in the heart of the regionally well centralised Budapest. The venue allows the guests to relax in the Royal Spa after a busy day or to make a gastronomic tour to the Hungarian kitchen and to enjoy the world's famous Hungarian wines. As an exclusive closing of the first day, guests are invited to join the unique Evening Programme at the historical Orfeum Concert Club within the Corinthia which is sponsored by PLASTRADE and BERICAP.

TEG aims to be working closely together with its key partners and uses several channels to do so. Online platforms are among the most efficient ways to keep up the continuous interaction as well as to transmit the latest news.

IP, Xellia Pharmaceuticals, Finesse, Forgó Damjanovic and Partners, Aptar Pharma, UPS Healthcare, Festo, and other esteemed business partners are sponsoring the congress.

For further information please visit: pharmconnect.eu or tegevents.eu

or contact:
Dalma Tabori
International PR & Online Marketing Manager
+36 1 219 5725

Click here for the complete issue.

news Medical technology experts to address the impact of innovation in shaping patient outcomes across Asia Pacific
news China biotech's 'coming out party' masks long road ahead
news SingHealth, Duke NUS and GSK to conduct large-scale big data study on asthma and COPD in Singapore
Asia Pacific Biotech News

Lady Ganga: Nilza'S Story
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
Healthcare Focus: LUNGS
Get to Know TCM
Diabetes: The Big Picture
The Piece of Your Mind - Brain Health/Science
Advocacies in Support of Rare Disease Patients
Food Science & Technology
Eye – the Window to your Soul
Infectious Diseases
A change of heart — Cardiovascular diseases
Diseases threatening our Children
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy